Galectin Therapeutics (GALT) Misfired In 2014
March 19, 2015 at 06:35 AM EDT
Galectin Therapeutics just cannot catch a break these days. They announced a Q4 loss this week, just a day after a law firm announced an investigation of the management team's investor relations program. It's fair to wonder what went wrong.
